Information Provided By: 
Fly News Breaks for May 23, 2018
CVS, AET
May 23, 2018 | 06:58 EDT
Cantor Fitzgerald analyst Steven Halper believes Aetna's risk/reward "remains compelling" with the shares trading 13% below his fundamental-based price target of $202. Excluding the impact of the CVS Health (CVS) merger, Aetna's 2018 is likely to be a transition year until the company's investments and improved Medicare Star ratings pay dividends in 2019, Halper tells investors in a research note. He keeps an Overweight rating on the shares.
News For AET;CVS From the Last 2 Days
